Boston Scientific Corp
BSX· NYSE
BSXBoston Scientific Corp
Source filing unavailable
derived · Computed from the longer spans the company filed.
| Metric | Q4 2012dderived from reported figures | Q4 2011dderived from reported figures | Q4 2010 | Q4 2009 |
|---|---|---|---|---|
| Revenue | $1.53B | $1.85B | $2.00B | $2.08B |
| Net Income | $61.00M | $107.00M | $236.00M | -$1.08B |
| EPS Diluted | — | — | $0.15 | -$0.71 |
Boston Scientific Corp · CIK 885725 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
